Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Veterinary medicine
Name of medicinal product: Cortico Veyxin
Active substances:
Estonian, English, Latin
ATC code: QH02AB06
Dosage form: suspension for injection
Strength: 8,95mg 1ml
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):  (last updated May 26, 2023)
Package information leaflet (PIL): EST  (last updated September 5, 2018)
Labelling:  (last updated September 5, 2018)
Indication: In horses, cattle, dogs and cats: Supportive treatment of acute non-infectious arthritis, bursitis, tenosynovitis or allergic skin disease. In cattle: Supportive treatment of primary ketosis (acetonaemia).
Safety features: No
Marketing authorization holder: Veyx-Pharma GmbH 
Marketing authorization number: 2113 
Marketing authorization issued on: September 5, 2018 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Decentralised 
Assessment report:  (last updated September 19, 2018) 
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1710201  Cortico Veyxin  suspension for injection  8,95mg 1ml 100ml 1TK  Prescription           
1710212  Cortico Veyxin  suspension for injection  8,95mg 1ml 100ml 6TK  Prescription           
1710223  Cortico Veyxin  suspension for injection  8,95mg 1ml 100ml 12TK  Prescription           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere